NEURONAL CONTROL OF MICTURITION VIA CANNABINOID (CB) TYPE 1 RECEPTORS - EVALUATION OF A CB1 KNOCKOUT MOUSE

被引：0
|
作者：
Fuellhase, Claudius
Campeau, Lysanne
Sibaev, Andrei
Storr, Martin
Gratzke, Christian
Stief, Christian
Hedlund, Petter
Andersson, Karl-Erik
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
121
引用
收藏
页码：E48 / E49
页数：2
相关论文
共 50 条
  • [31] Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
    Navarro, Gemma
    Varani, Katia
    Reyes-Resina, Irene
    Sanchez de Medina, Veronica
    Rivas-Santisteban, Rafael
    Sanchez-Carnerero Callado, Carolina
    Vincenzi, Fabrizio
    Casano, Salvatore
    Ferreiro-Vera, Carlos
    Canela, Enric, I
    Borea, Pier Andrea
    Nadals, Xavier
    Franco, Rafael
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [32] Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
    Navarro, Gemma
    Varani, Katia
    Lillo, Alejandro
    Vincenzi, Fabrizio
    Rivas-Santisteban, Rafael
    Raich, Iu
    Reyes-Resina, Irene
    Ferreiro-Vera, Carlos
    Borea, Pier Andrea
    Sanchez de Medina, Veronica
    Nadal, Xavier
    Franco, Rafael
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [33] Further evidence for the presence of cannabinoid CB1, receptors in mouse vas deferens
    Pertwee, RG
    JoeAdigwe, G
    Hawksworth, GM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 296 (02) : 169 - 172
  • [34] Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract
    Casu, MA
    Porcella, A
    Ruiu, S
    Saba, P
    Marchese, G
    Carai, MAM
    Reali, R
    Gessa, GL
    Pani, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 459 (01) : 97 - 105
  • [35] Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice
    Li, Xia
    Hempel, Briana J.
    Yang, Hong-Ju
    Han, Xiao
    Bi, Guo-Hua
    Gardner, Eliot L.
    Xi, Zheng-Xiong
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 43 : 38 - 51
  • [36] Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors
    Pryce, G.
    Baker, D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (04) : 519 - 525
  • [37] Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus
    Wittmann, Gabor
    Deli, Levente
    Kallo, Imre
    Hrabovszky, Erik
    Watanabe, Masahiko
    Liposits, Zsolt
    Fekete, Csaba
    JOURNAL OF COMPARATIVE NEUROLOGY, 2007, 503 (02) : 270 - 279
  • [38] CB1 and CB2 cannabinoid receptors are implicated in inflammatory hypersensitivity to pain
    Clayton, NM
    O'Shaughnessy, CT
    Marshall, F
    Bountra, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134
  • [39] Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors
    Govaerts, SJ
    Muccioli, GG
    Hermans, E
    Lambert, DM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 495 (01) : 43 - 53
  • [40] Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses
    Gobira, P. H.
    Joca, S. R.
    Moreira, F. A.
    ACTA NEUROPSYCHIATRICA, 2024, 36 (02) : 67 - 77
12345